Prior authorization (PA) is a time-consuming and costly burden on healthcare providers. With an increase in specialty medication spending, accounting for 70% of total drug spend, PAs are expected to become more stringent and restrictive. Marylou Buyse and Charline Shan share their insight and explore how the vertical integration mergers might impact PA for the better.

To read the full article, please click here.